Origin Therapeutics Holdings Inc.
ORIG.CN•CNQ
Origin Therapeutics Holdings Inc.
ORIG.CN•CNQ
Mkt Cap$1.41M
Sentiment
Phase 1 · Company Overview
Step 1: Overview
What the company does, where it operates, and who runs it.
Overview for Origin Therapeutics Holdings Inc.
Industry:Drug Manufacturers - Specialty & Generic
Sector:Healthcare
CEO:Michael Galego
Description:Origin Therapeutics Holdings Inc., an investment issuer, primarily focuses on investments in the psychedelic industry in Canada. It plans to invests in the research, design, development, testing, production, distribution, and sale of psychedelics and related activities. The company was formerly known as 1278700 B.C. Ltd. Origin Therapeutics Holdings Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada.
Address:N/A
Step 2: Infographics
Visual summary of the business at a glance.
Phase 2 · FRC Research
Step 3: Media
Videos and interviews covering the company.
Phase 3 · Financial Data
Step 4: Stock Data
Price chart, volume, and trading data.
ORIG.CN Stock Price
Step 5: Fair Value
What FRC thinks the stock is worth vs. the current price.
Step 6: Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Step 7: Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Step 8: Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Step 9: Financial Statements
Income statement, balance sheet, and cash flow statements.
Phase 4 · Peer Comparison
Step 10: Comparables
List of peer companies in the same industry.
Phase 5 · Ownership & News
Step 12: Institutional Ownership
Which funds and firms own the stock.
Step 13: Insider Trading
Recent buying and selling by company executives.
Step 14: Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
Step 15: News
Latest headlines and market coverage.
News
Latest Market News